Growth Metrics

Pacific Biosciences Of California (PACB) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -31.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.18%
Dec 31, 2025 -30.41%
Sep 30, 2025 31.55%
Jun 30, 2025 67.60%
Mar 31, 2025 28.03%
Dec 31, 2024 -38.20%
Jun 30, 2024 26.98%
Mar 31, 2024 -28.49%
Dec 31, 2023 -160.52%
Sep 30, 2023 90.06%
Jun 30, 2023 -77.31%
Mar 31, 2023 -9.85%
Dec 31, 2022 99.79%
Sep 30, 2022 -61.41%
Jun 30, 2022 -143.42%
Mar 31, 2022 -53.83%
Dec 31, 2021 56.60%
Jun 30, 2021 -482.21%
Mar 31, 2021 356.37%
Dec 31, 2020 50.25%
Sep 30, 2020 64.30%
Jun 30, 2020 -76.21%
Mar 31, 2020 47.54%
Dec 31, 2019 16.92%
Sep 30, 2019 49.99%
Jun 30, 2019 -55.73%
Mar 31, 2019 50.80%
Dec 31, 2018 -70.92%
Sep 30, 2018 127.28%
Jun 30, 2018 17.93%
Mar 31, 2018 51.09%
Dec 31, 2017 -122.93%
Sep 30, 2017 -51.29%
Jun 30, 2017 37.05%
Mar 31, 2017 -6.40%
Dec 31, 2016 46.05%
Sep 30, 2016 -27.71%
Jun 30, 2016 33.61%
Mar 31, 2016 -59.86%
Dec 31, 2015 -22.85%
Sep 30, 2015 47.36%
Jun 30, 2015 42.33%
Mar 31, 2015 -33.36%
Dec 31, 2014 -6.87%
Sep 30, 2014 32.99%
Jun 30, 2014 24.29%
Mar 31, 2014 30.77%
Dec 31, 2013 -34.85%
Sep 30, 2013 42.15%